EU Clears Varian's $16.4B Sale To Siemens Unit With Fixes
Law360 (February 19, 2021, 6:54 PM EST) -- The European Union's antitrust regulator approved German medical technology business Siemens Healthineers AG's $16.4 billion acquisition of Varian Medical Systems on Friday, after Siemens offered concessions to remedy the enforcer's competition concerns surrounding the deal.
The European Commission greenlit the merger, which will provide customers with comprehensive, end-to-end oncology services — covering screening and diagnosis to personalized treatment and post-treatment care. The merger was presented to the commission in late December, but the deal gave the regulator pause after its investigation revealed that it could potentially squeeze rivals from the medical imaging solutions and radiotherapy solutions markets.
"The foreclosure of competitors...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!